Investor AB
STOCKHOLM, V7
$14.4bn in 7 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 0.7% of the portfolio this quarter.
Value
$14.4bn
Stocks
7
Top 10 share
100.0%
Turnover
0.7%
What changed this quarter
New
Bought for the first time this quarter.
- Micron TechnologyMU<0.1% of the fund
Added
Bought more of a stock they already held.
- Cellebrite DICLBT<0.1% of the fund+36%
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
- CoherentCOHR-100%
- Kyivstar GroupKYIV-100%
- Corsair GamingCRSR-100%
- WhirlpoolWHR-100%
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| AstrazenecaAZN | 67.9% | $9.8bn | 51,587,810 | Held |
| NasdaqNDAQ | 32.0% | $4.6bn | 58,439,208 | Held |
| MediWoundMDWD | <0.1% | $13m | 872,093 | Held |
| Cellebrite DICLBT | <0.1% | $1m | 75,000 | +36% |
| Micron TechnologyMU | <0.1% | $542,516 | 470 | New |
| Verizon CommunicationsVZ | <0.1% | $478,442 | 11,300 | Held |
| Biomarin PharmaceuticalBMRN | <0.1% | $211,714 | 3,700 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 175.6% since 30 June 2025.
Where the money is
Health care68.0%
Financial services32.0%
Technology0.0%
Media & telecom0.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.